Resources Investment Advisors, Llc. Oncternal Therapeutics, Inc. Transaction History

Resources Investment Advisors, Llc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$0.28 - $0.79 $588 - $1,659	-2,100 Reduced 15.18%	11,731 $3,000
Q1 2023 May 10, 2023	BUY	$0.63 - $1.3 $8,713 - $17,980	13,831 New	13,831 $10,000
Q3 2022 Nov 08, 2022	SELL	$0.83 - $17.8 $22,299 - $478,232	-26,867 Reduced 66.42%	13,581 $12,000
Q2 2022 Aug 08, 2022	BUY	$0.7 - $1.56 $7,140 - $15,912	10,200 Added 33.72%	40,448 $45,000
Q1 2022 May 05, 2022	BUY	$1.37 - $2.43 $12,012 - $21,306	8,768 Added 40.82%	30,248 $42,000
Q4 2021 Feb 23, 2022	BUY	$2.27 - $4.39 $16,673 - $32,244	7,345 Added 51.96%	21,480 $49,000
Q3 2021 Nov 05, 2021	BUY	$3.37 - $4.76 $47,634 - $67,282	14,135 New	14,135 $58,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.